BofA Securities initiated coverage on U.S. Physical Therapy with a new price target
$USPH
Medical/Nursing Services
Health Care
BofA Securities initiated coverage of U.S. Physical Therapy with a rating of Buy and set a new price target of $138.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/16/2024 | $100.00 → $115.00 | Neutral → Buy | BofA Securities |
| 12/16/2024 | $113.00 | Mkt Outperform | JMP Securities |
| 10/7/2024 | $114.00 → $90.00 | Buy → Neutral | BofA Securities |
| 9/22/2023 | $108.00 | Overweight | JP Morgan |
| 6/30/2023 | $138.00 | Buy | BofA Securities |
| 12/14/2021 | $120.00 | Market Perform → Market Outperform | CJS Securities |
| 8/6/2021 | $130.00 → $139.00 | Outperform | Barrington Research |
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
CERT - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-A12B - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, presented at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, and Carey Hendrickson, Chief Financial Officer, presented at the 15th Annual East Coast IDEAS Conference on June 11, 2025. The presentations provided an overview of the Company. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 775 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post-operative care
U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services headquartered in Houston, Texas, today announced a dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas, Texas. U.S. Physical Therapy will maintain its primary listing on the New York Stock Exchange and trade with the same "USPH" ticker symbol on NYSE Texas. Chris Reading, Chairman and Chief Executive Officer, said, "We are honored to join NYSE Texas as a Founding Member and to champion the dynamic growth, energy and grit that define this great state. Being
Reports Record First Quarter Patient Volume U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the first quarter ended March 31, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $19.5 million for the three months ended March 31, 2025 ("2025 First Quarter"), an increase of $2.8 million, or 16.5%, from $16.8 million in the three months ended March 31, 2024 ("2024 First Quarter") primarily driven by acquisitions since the prior year period and an increase in net patien
U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services headquartered in Houston, Texas, today announced a dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas, Texas. U.S. Physical Therapy will maintain its primary listing on the New York Stock Exchange and trade with the same "USPH" ticker symbol on NYSE Texas. Chris Reading, Chairman and Chief Executive Officer, said, "We are honored to join NYSE Texas as a Founding Member and to champion the dynamic growth, energy and grit that define this great state. Being
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed Business Advisory Board (BAB). "I am very pleased to welcome Dr. Harris to our new Business Advisory Board," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "As we continue
~Highly Esteemed Growth Strategist and Financial Expert with Decades of Business Acumen~ NEW YORK, Oct. 18, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) is pleased to announce the appointment of Anne Motsenbocker to its national Board of Directors. We're honored & excited Anne has joined the national board to share her extensive business acumen in board governance.Motsenbocker resides in Dallas, Texas and is a former banker and seasoned board member bringing over 35 years of commercial banking and wealth management expertise due to the numerous roles she held at J